Title |
Tau Filaments and the Development of Positron Emission Tomography Tracers
|
---|---|
Published in |
Frontiers in Neurology, February 2018
|
DOI | 10.3389/fneur.2018.00070 |
Pubmed ID | |
Authors |
Michel Goedert, Yoshiki Yamaguchi, Sushil K. Mishra, Makoto Higuchi, Naruhiko Sahara |
Abstract |
A pathological pathway leading from soluble, monomeric to insoluble, filamentous Tau, is believed to underlie human Tauopathies. Cases of frontotemporal dementia are caused by dominantly inherited mutations inMAPT, the Tau gene. They show that dysfunction of Tau protein is sufficient to cause neurodegeneration and dementia. Extrapolation to the more common sporadic Tauopathies leads one to conclude that the pathological pathway is central to the development of all cases of disease, even if there are multiple reasons for Tau assembly. These findings are conceptually similar to those reported for beta-amyloid, alpha-synuclein and prion protein. Here, we provide an overview of Tau filaments and their positron emission tomography ligands. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 49 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 12 | 24% |
Student > Ph. D. Student | 11 | 22% |
Student > Bachelor | 5 | 10% |
Student > Master | 4 | 8% |
Other | 3 | 6% |
Other | 5 | 10% |
Unknown | 9 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Neuroscience | 12 | 24% |
Agricultural and Biological Sciences | 6 | 12% |
Medicine and Dentistry | 6 | 12% |
Biochemistry, Genetics and Molecular Biology | 5 | 10% |
Chemistry | 5 | 10% |
Other | 3 | 6% |
Unknown | 12 | 24% |